Cancer
Cancer Ongoing 2020 Michigan: Maria Pappas (248) 553-0606

S1806

SWOG/NRG Joint Study: Phase III Randomized Trial of Concurrent Chemoradiotherapy with or without Atezolizumab in Localized Muscle Invasive

Trial overview

Disease
Bladder cancer treatment and diagnosis
Topic
S1806
Description
Primary Objective:To compare bladder intact event-free survival (BI-EFS) for concurrent chemoradiation therapy (CRT) with and without atezolizumab in localized muscle invasive bladder cancer (MIBC).Patient Population:Patients with muscle invasive bladder cancer (MIBC) (T2-T4aN0M0).
Physicians

Dr. Alvaro A. Martinez

MD, FACR, FABS, FASTRO

Radiation Oncologist

Works at 5 centers.

Dr. Frank A. Vicini

MD, FACR, FASTRO

Radiation oncologist

Works at 3 centers.

Dr. Larry L. Kestin

MD, FACR

Radiation Oncologist

Works at 3 centers.

Dr. Thomas Boike

MD

Radiation Oncologist

Works at 3 centers.

Dr. Michael I. Ghilezan

MD, PhD

Radiation Oncologist

Works at 4 centers.

Dr. John Vito Antonucci

MD

Radiation Oncologist

Works at 4 centers.